Esteban López de Sá y Areses

La producción científica cardiovascular en España y en el contexto europeo y mundial (2003-2007)

Introduccion y objetivos La publicacion de articulos de investigacion ha aumentado de manera considerable en los ultimos anos en todas las areas biomedicas. El objetivo de este trabajo es determinar el lugar que ocupa la investigacion cardiologica espanola de calidad en el contexto europeo y mundial y su evolucion durante el quinquenio 2003-2007. Metodos Utilizando como fuente de datos la base de datos Science Citation Index Expanded de Thomson Reuters, se comparo la produccion cientifica cardiovascular espanola con la de los paises de la Union Europea y los mas destacados del mundo, asi como la productividad relativa respecto al numero de habitantes y producto interior bruto y el numero de citas recibidas en las revistas del area «Cardiac & Cardiovascular Systems» del Journal Citation Reports (CCS-JCR). Resultados Espana ocupa el sexto puesto en el ranking europeo y el noveno en el mundial de la produccion cientifica, pasando al decimo mundial si se consideran unicamente las revistas del primer cuartil del area CCS-JCR. En numero de citas recibidas, Espana ocupa el septimo lugar europeo y undecimo mundial. En la productividad relativa respecto al numero de habitantes y el producto interior bruto, la posicion espanola es menos favorable, ocupando la decimoquinta y la decimoctava posicion, respectivamente. Conclusiones En investigacion cardiovascular, Espana ocupa posiciones similares a otras areas biomedicas, si bien su situacion es menos ventajosa respecto a algunos indicadores demograficos y economicos. Para que se mantengan los niveles adecuados de investigacion, es necesario que los gobiernos y las sociedades cientificas europeas consideren el fomento de la investigacion cardiologica de alta calidad como un objetivo primordial.

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

Improvements in early detection and treatment have markedly reduced cancer-related mortality. However survival not only depends on effectively cure cancer, but prevention, diagnosis and treatment of cancer-related complications is also needed. Cardiovascular toxicity is a widespread problem across many classes of therapeutic schemes, however scientific evidence in the management of cardiovascular complications of onco-hematological patients is scarce, as these patients have been systematically excluded from clinical trials and current recommendations are based on expert consensus. Multidisciplinary teams are mandatory to decrease morbidity and mortality from both cardiotoxicity and cancer itself. An excessive concern for the occurrence of cardiovascular toxicity, can avoid potentially curative therapies, while underestimating this risk, increases long-term mortality of cancer survivors. The objective of this consensus document, developed in collaboration of the Spanish Society of Cardiology, the Spanish Society of Medical Oncology, the Spanish Society of Radiation Oncology and the Spanish Society of Hematology, is to update the necessary concepts and expertise on cardio-onco-hematology that enable its application in daily clinical practice and to promote the development of local multidisciplinary teams, to improve the cardiovascular health of patients with cancer.

Cardiovascular Scientific Production in Spain and in the European and Global Context (2003-2007)

INTRODUCTION AND OBJECTIVES The publication of research articles has increased considerably in recent years in all biomedical fields. The present study examines the position of Spanish quality research in cardiology in the European and world context, and its evolution during the 5-year period 2003-2007. METHODS Using the Science Citation Index Expanded of Thomson Reuters as data source, we compared Spanish cardiovascular scientific production with that of the rest of countries in the European Union and of the most important countries worldwide, along with relative productivity as per number of inhabitants and Gross Domestic Product, and the number of citations in the journals of the <<Cardiac and Cardiovascular Systems>> area of the Journal Citation Reports (CCS-JCR). RESULTS Spain ranks sixth in the European Union and ninth worldwide in scientific production (tenth worldwide if only the journals of the first quartile of the CCS-JCR area are considered). As regards the number of citations received, Spain ranks seventh in the European Union and eleventh worldwide. In terms of relative productivity as per number of inhabitants and Gross Domestic Product, the Spanish ranking is less favorable (positions 15 and 18, respectively). CONCLUSIONS The ranking of Spanish cardiovascular research is similar to that of other biomedical fields, though its position is less favorable in relation to certain demographic and economical indicators. In order to maintain adequate investigational levels, it is necessary for the European governments and scientific societies to regard the promotion of high-quality cardiological research as a priority concern.

Infective Endocarditis of Unusual Location Following Surgical Correction of a Complex Congenital Heart Disease

A 40‐year‐old woman from Ecuador diagnosed with a complex congenital heart disease was admitted complaining of fever chills, night sweats, and productive cough 6 months after surgical correction of the anomalies. An echocardiography showed vegetations located on the interatrial pericardium patch. To the best of our knowledge, this is the first reported case of postoperative infective endocarditis on this location. Copyright

The Scope of Cardiological Competence in New Clinical Settings. Spanish Society of Cardiology Consensus Document

Cardiology is the medical discipline or specialty responsible for the prevention, diagnosis, and treatment of cardiovascular disease. As this is the major cause of morbidity and mortality in Spain and the European Union,1 cardiology professionals have, with respect to other medical specialists, an additional moral authority and responsibility derived from the relevance for society of an excellent performance in combating cardiovascular disease. Hence the importance of keeping up with the rapid transitions that are currently taking place at the social, administrative, educational, health care, and professional levels, transitions that necessarily generate novel contexts for the practice of cardiology and for its professionals. At the end of 2005, the Spanish Society of Cardiology (SSC), by virtue of its leadership role in combating cardiovascular disease, decided to undertake a project, applying a synthetic approach to the process matrix, involving the professionals in cardiology and in other medical specialties, the health care administrations, the pharmaceutical industry, and biotechnology companies, the institutions, the patients and the general population; these processes will ultimately play a role in the development of the field of cardiology, in the work of The Scope of Cardiological Competence in New Clinical Settings

Special ArticlesThe Scope of Cardiological Competence in New Clinical Settings: A Consensus Document of the Spanish Society of Cardiology

Cardiology is the medical discipline or specialty responsible for the prevention, diagnosis, and treatment of cardiovascular disease. As this is the major cause of morbidity and mortality in Spain and the European Union,1 cardiology professionals have, with respect to other medical specialists, an additional moral authority and responsibility derived from the relevance for society of an excellent performance in combating cardiovascular disease. Hence the importance of keeping up with the rapid transitions that are currently taking place at the social, administrative, educational, health care, and professional levels, transitions that necessarily generate novel contexts for the practice of cardiology and for its professionals. At the end of 2005, the Spanish Society of Cardiology (SSC), by virtue of its leadership role in combating cardiovascular disease, decided to undertake a project, applying a synthetic approach to the process matrix, involving the professionals in cardiology and in other medical specialties, the health care administrations, the pharmaceutical industry, and biotechnology companies, the institutions, the patients and the general population; these processes will ultimately play a role in the development of the field of cardiology, in the work of The Scope of Cardiological Competence in New Clinical Settings

The Scope of Cardiological Competence in New Clinical Settings: A Consensus Document of the Spanish Society of Cardiology

Cardiology is the medical discipline or specialty responsible for the prevention, diagnosis, and treatment of cardiovascular disease. As this is the major cause of morbidity and mortality in Spain and the European Union,1 cardiology professionals have, with respect to other medical specialists, an additional moral authority and responsibility derived from the relevance for society of an excellent performance in combating cardiovascular disease. Hence the importance of keeping up with the rapid transitions that are currently taking place at the social, administrative, educational, health care, and professional levels, transitions that necessarily generate novel contexts for the practice of cardiology and for its professionals. At the end of 2005, the Spanish Society of Cardiology (SSC), by virtue of its leadership role in combating cardiovascular disease, decided to undertake a project, applying a synthetic approach to the process matrix, involving the professionals in cardiology and in other medical specialties, the health care administrations, the pharmaceutical industry, and biotechnology companies, the institutions, the patients and the general population; these processes will ultimately play a role in the development of the field of cardiology, in the work of The Scope of Cardiological Competence in New Clinical Settings